LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
1.7783
3.66 27.76 1 283 0.0035 -0.6287
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
3.66 27.76 677 283 2.3844 1.5914
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
5.36 27.76 591 320 1.8448 1.3790
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
5.36 27.76 760 320 2.3724 1.5548
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
7.06 27.76 659 360 1.8306 1.3554
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
7.06 27.76 6 360 0.0167 -0.3392
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
7.06 27.76 875 360 2.4306 1.5431
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.76 27.76 1 401 0.0025 -0.5779
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.76 27.76 724 401 1.8048 1.3312
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.76 27.76 7 401 0.0175 -0.3006
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
8.76 27.76 930 401 2.3184 1.4877
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.46 27.76 4 438 0.0091 -0.3852
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.46 27.76 777 438 1.7714 1.3088
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.46 27.76 8 438 0.0182 -0.2683
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
10.46 27.76 1018 438 2.3208 1.4709
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.17 27.76 4 489 0.0082 -0.3738
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.17 27.76 808 489 1.6521 1.2579
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.17 27.76 19 489 0.0388 -0.0875
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
12.17 27.76 1069 489 2.1858 1.4159
MN20160318_Q01
L17
MCF 10A-H2B-mCherry Dasatinib
1.7783
13.87 27.76 2 604 0.0033 -0.4466
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
13.87 27.76 840 604 1.3891 1.1535
MN20160318_Q01
H17
MCF 10A-H2B-mCherry Dasatinib
1.7783
13.87 27.76 23 604 0.0380 -0.0414
MN20160318_Q01
L17